Inflammatory Bowel Diseases

Titel Veröffentlichungsdatum Sprache Zitate
Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohnʼs disease2009/06/01English276
Th1/Th2 Cells1999/11/01English269
Dietary Risk Factors for Inflammatory Bowel Disease2005/02/01English268
Dysbiosis of fecal microbiota in Crohnʼs disease patients as revealed by a custom phylogenetic microarray2010/12/01English255
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation2019/05/21English255
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD2008/04/01English246
Toll-like receptors in inflammatory bowel diseases: A decade later2010/09/01English245
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease2018/02/16English244
Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses—Part I2018/03/19English243
Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety1999/05/01English236
Ulcerative colitis2009/12/01English235
Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 12018/05/23English231
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus2010/11/01English231
A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis2001/11/01English230
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse2009/08/01English227
Nitric Oxide in Inflammatory Bowel Disease2003/05/01English225
Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice2002/03/01English225
Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases2008/11/01English215
Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation2011/11/01English215
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies2012/10/01English215
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate†2010/07/01English214
Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys2006/08/01English211
Pain and inflammatory bowel disease2009/05/01English207
Identification of microRNAs associated with ileal and colonic Crohnʼs disease†2010/10/01English207
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)2009/08/01English207
A population-based study of fatigue and sleep difficulties in inflammatory bowel disease2011/09/01English204
Inflammatory Bowel Disease and Smoking2004/11/01English203
Highlighting new phylogenetic specificities of Crohnʼs disease microbiota2011/01/01English202
High incidence of Crohnʼs disease in Canterbury, New Zealand: Results of an epidemiologic study2006/10/01English200
Active Crohnʼs disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora2008/02/01English199